5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.
作者信息
Brugarolas A, Rivas A, Lacave A J, Gonzalez-Palacois F, Froufe A
出版信息
Cancer Chemother Rep. 1975 Sep-Oct;59(5):1025-6.
PMID:1106844
Abstract
摘要
相似文献
1
5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.5-氟尿嘧啶（NSC-19893）与环磷酰胺（NSC-26271）治疗支气管癌的临床研究比较：临床研究结果
Cancer Chemother Rep. 1975 Sep-Oct;59(5):1025-6.
2
Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Cancer Chemother Rep. 1974 Nov-Dec;58(6):883-8.
3
BCNU (NSC-409962) in the treatment of bronchogenic carcinoma.卡氮芥（NSC - 409962）用于治疗支气管癌。
Cancer Chemother Rep. 1972 Dec;56(6):739-43.
4
5
Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
Cancer Chemother Rep 3. 1973 Mar;4(2):161-4.
6
[Polychemotherapy of bronchial carcinoma].
Minerva Med. 1970 Jun 9;61(46):2567-70.
7
Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
Cancer Chemother Rep 3. 1973 Mar;4(2):207-13.
8
Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
Cancer Chemother Rep 3. 1973 Mar;4(2):125-32.
9
[Polychemotherapeutic treatment of pulmonary neoplasms].[肺部肿瘤的多药联合治疗]
G Pneumol. 1970 Jun;14(3):164-92.
10
Zotero 插件